Patient Access
The company is now an in-network provider with numerous insurers and commercial and Medicare Advantage plans, expanding its reach to all 50 states.
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.
The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.
The company will use the funds to expand its team.
Dr. Dennis Truong, regional telemedicine/mobility director at Kaiser Permanente, highlights the challenges of implementing digital therapeutics in the care system and its ultimate value in improving patients' and providers’ care journeys.
Naama Stauber Breckler, CEO and cofounder of Better Health, discusses the company's latest strategic funding round and how it plans to use the investment.
The direct-to-consumer platform will be integrated into Uwill's Urise wellness offerings.
CALFREE uses input from optical sensors commonly found in smartwatches or commercial smartphones to collect blood pressure data.
